LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Shang, Hongcai" AU="Shang, Hongcai"
  2. AU="Ho, Collin Elijah Rui Hung"
  3. AU="Akbar, Ansa"
  4. AU="Heinrich, N"
  5. AU="Almeida, Carolina Aparecida de Faria"
  6. AU="Müller, Pavel"
  7. AU="Carosi, Mariantonia"
  8. AU="Bindu Sen"
  9. AU="Kohaut, Eva"
  10. AU="Adam F. Cohen"
  11. AU="Daniele Tomassoni"
  12. AU="Bergado, Gretchen"
  13. AU="Schomberg, Harry H"
  14. AU="Halder, Prolay"
  15. AU="Miyaguchi, Ken"
  16. AU="Zhan, Na-ping"
  17. AU="Stewart Quigg"

Suchergebnis

Treffer 1 - 10 von insgesamt 334

Suchoptionen

  1. Artikel: Editorial: Novel insights into the comorbidities and mortality in patients with diabetes.

    Li, Sen / Dou, Haiqiang / Wang, Ping / Shang, Hongcai

    Frontiers in endocrinology

    2024  Band 15, Seite(n) 1406131

    Mesh-Begriff(e) Humans ; Comorbidity ; Diabetes Mellitus/mortality ; Diabetes Mellitus/epidemiology ; Diabetes Complications/mortality ; Diabetes Complications/epidemiology ; Diabetes Mellitus, Type 2/mortality ; Diabetes Mellitus, Type 2/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2024-04-10
    Erscheinungsland Switzerland
    Dokumenttyp Editorial ; Introductory Journal Article
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2024.1406131
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Go with the flow, emerge as the times require and propel the modernization of traditional Chinese medicine to a new era

    Shang Hong-Cai

    TMR Modern Herbal Medicine, Vol 1, Iss 1, Pp 1-

    2018  Band 1

    Schlagwörter Medicine ; R
    Sprache Englisch
    Erscheinungsdatum 2018-01-01T00:00:00Z
    Verlag TMR publishing group
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  3. Artikel: Pharmacological properties of Polygonatum and its active ingredients for the prevention and treatment of cardiovascular diseases.

    Lin, Hongyuan / Wang, Wenhui / Peng, Mengqi / Kong, Yifan / Zhang, Xiaowei / Wei, Xiaohong / Shang, Hongcai

    Chinese medicine

    2024  Band 19, Heft 1, Seite(n) 1

    Abstract: Despite continued advances in prevention and treatment strategies, cardiovascular diseases (CVDs) remain the leading cause of death worldwide, and more effective therapeutic methods are urgently needed. Polygonatum is a traditional Chinese herbal ... ...

    Abstract Despite continued advances in prevention and treatment strategies, cardiovascular diseases (CVDs) remain the leading cause of death worldwide, and more effective therapeutic methods are urgently needed. Polygonatum is a traditional Chinese herbal medicine with a variety of pharmacological applications and biological activities, such as antioxidant activity, anti-inflammation, antibacterial effect, immune-enhancing effect, glucose regulation, lipid-lowering and anti-atherosclerotic effects, treatment of diabetes and anticancer effect. There has also been more and more evidence to support the cardioprotective effect of Polygonatum in recent years. However, up to now, there has been a lack of comprehensive studies on the active ingredients and their pharmacotoxicological effects related to cardiovascular diseases. Therefore, the main active components of Polygonatum (including Polysaccharides, Flavonoids, Saponins) and their biological activities were firstly reviewed in this paper. Furthermore, we summarized the pharmacological effects of Polygonatum's active components in preventing and treating CVDs, and its relevant toxicological investigations. Finally, we emphasize the potential of Polygonatum in the prevention and treatment of CVDs.
    Sprache Englisch
    Erscheinungsdatum 2024-01-02
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2260322-0
    ISSN 1749-8546
    ISSN 1749-8546
    DOI 10.1186/s13020-023-00871-0
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Prevention and treatment of anthracycline-induced cardiotoxicity: A bibliometric analysis of the years 2000-2023.

    Kong, Yifan / Wei, Xiaohong / Zhang, Di / Lin, Hongyuan / Peng, Mengqi / Shang, Hongcai

    Heliyon

    2024  Band 10, Heft 9, Seite(n) e29926

    Abstract: Aims: This study aimed to evaluate the global research trend in the prevention and treatment of cardiotoxicity caused by anthracyclines from 2000 to 2023, and to explore international cooperation, research hotspots, and frontier trends.: Methods: The ...

    Abstract Aims: This study aimed to evaluate the global research trend in the prevention and treatment of cardiotoxicity caused by anthracyclines from 2000 to 2023, and to explore international cooperation, research hotspots, and frontier trends.
    Methods: The articles on the prevention and treatment of anthracycline-induced cardiotoxicity published from 2000 to 2023 were searched by Web of Science. The bibliometrics software CiteSpace was used for visual analysis of countries, institutions, journals, authors, cited authors, cited references, and keywords.
    Results: This study analyzed the current status of global research on the prevention and treatment of cardiotoxicity caused by anthracyclines. A total of 3,669 papers were searched and 851 studies were included. The number of publications increased gradually throughout the years.
    Conclusions: This study provided valuable information for cardio-oncology researchers to identify potential collaborators and institutions, discover hot topics, and explore new research directions. The prevention and treatment of anthracycline-induced cardiotoxicity focuses on early detection and timely treatment. The results of the current clinical studies on the treatment of anthracycline-induced cardiotoxicity are contradictory, and more studies are needed to provide more reliable clinical evidence in the future.
    Sprache Englisch
    Erscheinungsdatum 2024-04-21
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2835763-2
    ISSN 2405-8440
    ISSN 2405-8440
    DOI 10.1016/j.heliyon.2024.e29926
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel: Optimization of evidence-based research in the prevention and treatment of coronary heart disease with traditional Chinese medicine: A comprehensive review

    Shang, Hongcai / Zhang, Kaige / Guan, Zhiyue / Zhang, Xiaoyu

    Beijing University of Chinese Medicine Journal of traditional Chinese medical sciences. 2022 Apr. 04,

    2022  

    Abstract: Coronary heart disease (CHD) has severely impacted the lives and health of patients for ages. Although the modern methods used for the prevention and treatment of CHD have been increasingly perfected, clinical problems remain that require solutions. In ... ...

    Abstract Coronary heart disease (CHD) has severely impacted the lives and health of patients for ages. Although the modern methods used for the prevention and treatment of CHD have been increasingly perfected, clinical problems remain that require solutions. In the prevention and treatment of CHD with traditional Chinese medicine (TCM), great therapeutic advantages have been demonstrated. However, the expression of its advantages relies on scientific evidence-based research and evaluation, which require further optimization and improvement. Therefore, this review aims to comprehensively emphasize our understanding of the current deficiencies in TCM evidence-based studies and the necessity of adopting scientific evidence-based optimization methods for use in research. In this process, evidence should be produced in a standard manner, and the advantages of TCM patterns should be accurately stated because these factors contribute to efficient transformation and proper verification of the obtained evidence. Additionally, focusing on patient-oriented medicine and doctor–patient relationships is also essential. These methods are of great significance to prove the clinical efficacy of TCM and promote its development.
    Schlagwörter Oriental traditional medicine ; coronary disease ; research and development ; therapeutics
    Sprache Englisch
    Erscheinungsverlauf 2022-0404
    Erscheinungsort Elsevier B.V.
    Dokumenttyp Artikel
    Anmerkung Pre-press version
    ZDB-ID 2834228-8
    ISSN 2095-7548 ; 2589-0395
    ISSN 2095-7548 ; 2589-0395
    DOI 10.1016/j.jtcms.2022.04.004
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Association of Drinking Herbal Tea with Activities of Daily Living among Elderly: A Latent Class Analysis.

    Tao, Liyuan / Liao, Jiaojiao / Zheng, Rui / Zhang, Xiaoyu / Shang, Hongcai

    Nutrients

    2023  Band 15, Heft 12

    Abstract: The aim of this study was to explore whether drinking herbal tea and tea would positively benefit activities of daily living (ADL) in the elderly. We used data from the Chinese longitudinal healthy longevity survey (CLHLS) to explore the association. ... ...

    Abstract The aim of this study was to explore whether drinking herbal tea and tea would positively benefit activities of daily living (ADL) in the elderly. We used data from the Chinese longitudinal healthy longevity survey (CLHLS) to explore the association. Drinking herbal tea and drinking tea were divided into three groups using latent class analysis (LCA): frequently, occasionally, and rarely. ADL disability was measured by the ADL score. Multivariate COX proportional hazards models with competing risks were used to explore the impact of drinking herbal tea and tea on ADL disability, statistically adjusted for a range of potential confounders. A total of 7441 participants (mean age 81.8 years) were included in this study. The proportions of frequently and occasionally drinking herbal tea were 12.0% and 25.7%, respectively. Additionally, 29.6% and 28.2% of participants reported drinking tea, respectively. Multivariate COX regression showed that compared with rarely drinking, frequently drinking herbal tea could effectively reduce the incidence of ADL disability (HR = 0.85, 95% CI = 0.77-0.93,
    Mesh-Begriff(e) Male ; Humans ; Female ; Aged ; Aged, 80 and over ; Activities of Daily Living ; Teas, Herbal ; Latent Class Analysis ; Longevity ; Longitudinal Studies ; Disabled Persons ; Tea ; China/epidemiology
    Chemische Substanzen Teas, Herbal ; Tea
    Sprache Englisch
    Erscheinungsdatum 2023-06-19
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu15122796
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Association of medicinal plant consumption with all-cause mortality and cognitive impairment in older adult: A large prospective cohort study.

    Tao, Liyuan / Liao, Jiaojiao / Zhang, Xiaoyu / Zheng, Rui / Shang, Hongcai

    Phytomedicine : international journal of phytotherapy and phytopharmacology

    2023  Band 119, Seite(n) 154995

    Abstract: Background: Panax ginseng and other medicinal plants have long been believed to have beneficial effects on health, and there is substantial evidence supporting their mechanisms of action. However, the extent of the health benefits derived from consuming ...

    Abstract Background: Panax ginseng and other medicinal plants have long been believed to have beneficial effects on health, and there is substantial evidence supporting their mechanisms of action. However, the extent of the health benefits derived from consuming these medicinal plants lacks substantial evidence from large-scale longitudinal population studies. The purpose of this study was to analyze the effect of consuming these medicinal plants on all-cause mortality and cognitive impairment.
    Methods: A population-based cohort study was conducted using the Chinese Longitudinal Healthy Longevity Survey (CLHLS), which was established in 1998 and has been followed up till now. The main exposure was the frequency of eating medicinal plants, including Panax ginseng, Astragalus membranaceus, Lycium barbarum, Angelica sinensis, etc. According to the consumption patterns of medicinal plants, the participants were divided into three groups: frequent use, occasional use, and rarely or never use group. The participants were individually tracked to determine their mortality and cognitive impairment status during the period from 2008 to 2018. Cox proportional hazards regression and competing risk model were used to calculate the hazard ratio (HR) for the association between the use of medicinal plants and the all-cause mortality and cognitive impairment.
    Results: Among 13,918 participants, the average age was 87.2 ± 11.3 years old, and 70.1% (9,754/13,918) of the participants died during follow-up. The proportion of those frequently using, occasionally using, and rarely using medicinal plants was 8.4%, 20.7%, and 70.8%, respectively. Compared with the rarely or never use group, the occasional and frequent use groups demonstrated significantly lower risks for all-cause mortality, with HR of 0.75 (95% CI: 0.71 - 0.79) and 0.53 (95% CI: 0.49 - 0.58), respectively. The protective effect of medicinal plants against all-cause mortality decreased with increasing age in the subgroup analysis. Additionally, frequent use of medicinal plants reduced the risk of cognitive impairment in the competing risk model (HR = 0.73, 95% CI: 0.60 - 0.87). However, there was no protective effect on cognitive function for those who occasional use medicinal plants.
    Conclusion: In elderly individuals, occasional and frequent use of medicinal plants was associated with reductions in risk of all-cause mortality, and frequent use of medicinal plants could reduce the risk of cognitive impairment.
    Mesh-Begriff(e) Humans ; Aged ; Aged, 80 and over ; Cohort Studies ; Prospective Studies ; Plants, Medicinal ; Longitudinal Studies ; Cognitive Dysfunction/drug therapy ; China/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2023-07-24
    Erscheinungsland Germany
    Dokumenttyp Journal Article
    ZDB-ID 1205240-1
    ISSN 1618-095X ; 0944-7113
    ISSN (online) 1618-095X
    ISSN 0944-7113
    DOI 10.1016/j.phymed.2023.154995
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel: The chemical components, action mechanisms, and clinical evidences of YiQiFuMai injection in the treatment of heart failure.

    Lv, Shichao / Wang, Yunjiao / Zhang, Wanqin / Shang, Hongcai

    Frontiers in pharmacology

    2022  Band 13, Seite(n) 1040235

    Abstract: YiQiFuMai injection (YQFM), derived from Shengmai Powder, is wildly applied in the treatment of cardiovascular diseases, such as coronary heart disease and chronic cardiac insufficiency. YiQiFuMai injection is mainly composed of Radix ... ...

    Abstract YiQiFuMai injection (YQFM), derived from Shengmai Powder, is wildly applied in the treatment of cardiovascular diseases, such as coronary heart disease and chronic cardiac insufficiency. YiQiFuMai injection is mainly composed of Radix of
    Sprache Englisch
    Erscheinungsdatum 2022-11-24
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2022.1040235
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Trimethylamine oxide: a potential target for heart failure therapy.

    Lv, Shichao / Wang, Yunjiao / Zhang, Wanqin / Shang, Hongcai

    Heart (British Cardiac Society)

    2022  Band 108, Heft 12, Seite(n) 917–922

    Abstract: Heart failure (HF) is a clinical syndrome in the late stage of cardiovascular disease and is associated with high prevalence, mortality and rehospitalisation rate. The pathophysiological mechanisms of HF have experienced the initial 'water-sodium ... ...

    Abstract Heart failure (HF) is a clinical syndrome in the late stage of cardiovascular disease and is associated with high prevalence, mortality and rehospitalisation rate. The pathophysiological mechanisms of HF have experienced the initial 'water-sodium retention' mode to 'abnormal hemodynamics' mode, and subsequent to 'abnormal activation of neuroendocrine' mode, which has extensively promoted the reform of HF treatment and updated the treatment concept. Since the Human Microbiome Project commencement, the study on intestinal microecology has swiftly developed, providing a new direction to reveal the occurrence of diseases and the mechanisms behind drug effects. Intestinal microecology comprises the gastrointestinal lumen, epithelial secretion, food entering the intestine, intestinal flora and metabolites. Choline and L-carnitine in the diet are metabolised to trimethylamine (TMA) by the intestinal micro-organisms, with TMA being absorbed into the blood. TMA then enters the liver through the portal vein circulation and is oxidised to trimethylamine oxide (TMAO) by the hepatic flavin-containing mono-oxygenase (FMO) family, especially FMO3. The circulating TMAO levels are associated with adverse outcomes in HF (mortality and readmission), and lower TMAO levels indicate better prognosis. As HF progresses, the concentration of TMAO in patients gradually increases. Whether the circulating TMAO level can be decreased by intervening with the intestinal microflora or relevant enzymes, thereby affecting the prognosis of patients with HF, has become a research hotspot. Therefore, based on the HF intestinal hypothesis, exploring the treatment strategy for HF targeting the TMAO metabolite of the intestinal flora may update the treatment concept in HF and improve its therapeutic effect.
    Mesh-Begriff(e) Cardiotonic Agents ; Carnitine/metabolism ; Choline/metabolism ; Diuretics ; Gastrointestinal Microbiome/physiology ; Heart Failure/drug therapy ; Humans ; Methylamines
    Chemische Substanzen Cardiotonic Agents ; Diuretics ; Methylamines ; trimethyloxamine (FLD0K1SJ1A) ; Choline (N91BDP6H0X) ; Carnitine (S7UI8SM58A)
    Sprache Englisch
    Erscheinungsdatum 2022-05-25
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 1303417-0
    ISSN 1468-201X ; 1355-6037
    ISSN (online) 1468-201X
    ISSN 1355-6037
    DOI 10.1136/heartjnl-2021-320054
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel: [Screening methods of traditional Chinese medicine for coronary heart disease and angina pectoris: an exploration based on core outcome set and fuzzy comprehensive evaluation].

    Qiu, Rui-Jin / Lei, Xiang / Chen, Jing / Shang, Hong-Cai

    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

    2022  Band 47, Heft 1, Seite(n) 265–270

    Abstract: It was pointed out in Opinions on Promoting the Inheritance, Innovation and Development of Traditional Chinese Medicine issued by the State Council in 2019 that 100 varieties of traditional Chinese medicine(TCM) with unique curative effects should be ... ...

    Abstract It was pointed out in Opinions on Promoting the Inheritance, Innovation and Development of Traditional Chinese Medicine issued by the State Council in 2019 that 100 varieties of traditional Chinese medicine(TCM) with unique curative effects should be screened out within about three years. Due to the multi-component and multi-target mechanisms of TCM varieties, it is difficult to directly and simply evaluate their multi-dimensional clinical value using methods applicable to chemical or biological agents. The heterogeneity of outcomes for similar TCM makes it difficult to determine the advantages of similar products. The fuzzy comprehensive evaluation method that is developed on the basis of core outcome set and fuzzy mathematics for clinical efficacy evaluation of TCM may solve these problems. This study developed a fuzzy comprehensive evaluation model for the clinical efficacy evaluation of Chinese patent me-dicines for coronary heart disease and angina pectoris, and selected the previous normative studies with complete or incomplete data for verifying the model application. The results showed that original studies with complete data failed to evaluate and compare the comprehensive efficacy of different interventions. The original research only mentioned the advantages and disadvantages of different interventions in different aspects. The comprehensive clinical efficacy of three different interventions obtained through fuzzy comprehensive evaluation was all graded as level Ⅱ. The original research with incomplete data drew the same conclusions as the fuzzy comprehensive evaluation, and the results of fuzzy comprehensive evaluation can provide more comprehensive information. Therefore, the fuzzy comprehensive evaluation shows the products with overall advantages of clinical efficacy, which may become a feasible method for the screening of TCM.
    Mesh-Begriff(e) Angina Pectoris ; Coronary Disease/diagnosis ; Coronary Disease/drug therapy ; Drugs, Chinese Herbal/therapeutic use ; Humans ; Medicine, Chinese Traditional ; Treatment Outcome
    Chemische Substanzen Drugs, Chinese Herbal
    Sprache Chinesisch
    Erscheinungsdatum 2022-02-17
    Erscheinungsland China
    Dokumenttyp Journal Article
    ZDB-ID 1004649-5
    ISSN 1001-5302 ; 0254-0029
    ISSN 1001-5302 ; 0254-0029
    DOI 10.19540/j.cnki.cjcmm.20210729.501
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang